🔴 Cue Biopharma is trading 7.9% down in pre-market

Cue Biopharma is trading at $17.00, down 7.86% in pre-market, with the reason for the decline unclear.

• No clear company-specific announcement or catalyst for October 27 was identified in the available news search. Recent coverage centers on September’s CUE-221 Phase 2 results, not a new overnight event.
• Major indices in the supplied pre-market context are modestly higher, so the market backdrop does not explain the decline.